Acrivon Therapeutics (ACRV) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
ACRV is expected to report earnings to rise 30.51% to -76 cents per share on March 26
Q4'24
Est.
$-0.77
Q3'24
Beat
by $0.15
Q2'24
Beat
by $0.23
Q1'24
Beat
by $0.06
Q4'23
Missed
by $0.14
The last earnings report on November 13 showed earnings per share of -58 cents, beating the estimate of -74 cents. With 79.50K shares outstanding, the current market capitalization sits at 179.97M.